Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MCI Santé Animale is a leading Moroccan veterinary pharmaceutical company specializing in the development, manufacture, and marketing of animal health products. Founded in 1985 and headquartered in Mohammedia, the company operates a state-of-the-art GMP-certified facility producing a wide range of vaccines and pharmaceutical specialties for livestock and poultry. Their portfolio includes viral and bacterial vaccines, antibiotics, and antiparasitics tailored to the epidemiological needs of the African and Middle Eastern markets. In 2016, the company became a subsidiary of Ceva Santé Animale, significantly expanding its global reach and R&D capabilities. MCI is recognized as the first Moroccan laboratory to export veterinary vaccines, serving over 30 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MCI Santé Animale.